In parallel, the glomerular ox-LDL deposition in PPP-administrated KL+/−DKD displayed significant remission but appeared more aggravated in IGF2-treated TgKL DKD (Fig. 5E). The gene discussed is IGF2; the disease is diabetic kidney disease.